ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1170

Cortical Bone Erosion in the 2nd Metacarpal Bone Head: Association with Its Bone Mineral Density by HR-pQCT in Rheumatoid Arthritis Patients

Camille Figueiredo1, Mariana Perez 1, Ana Cristina de Medeiros Ribeiro 2, Valeria Caparbo 1 and Rosa Pereira 3, 1Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Hand disorders, HR-pQCT and bone density, physical function, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Periarticular trabecular bone loss and local cortical bone erosions are typical features of bone disease in rheumatoid arthritis (RA) 1 . Little, however, is known about the interactions between periarticular bone loss and local bone erosions. The purpose of this study was test whether bone mineral density (BMD) in metacarpophalangeal (MCP) head, radius or tibia are associated with cortical bone erosions in RA patients.

Methods: Forty-seven RA female patients underwent high-resolution quantitative computed tomography (HR-pQCT) of 2 nd MCP joints of the dominant hand, and non-dominant distal radius and tibia in a cross-sectional study. Erosion volumewas assessed by the semi-automated Medical Image Analysis Framework (MIAF) software 2 . Clinical and laboratory variables were assessed, as well as Health Assessment Questionnaire (HAQ) and Hand Grip test. Trabecular bone mineral density (BMD) was measured in 4 particular volumes of interest (VOI-1-4= 1 the nearest to erosion) around the bone erosions (Figure 1). Further, total BMD of metacarpal head was also analyzed. Univariate and multivariate analysis were done to find out a relationship between erosion volume and BMD of metacarpal head, radius and tibia.

Results: The mean age was 40.2±5.9yrs, mean of disease duration 10.9±4.8yrs, median of disease activity score-28 (DAS-28) 2.66(1.97, 3.00), mean of HAQ 0.88±0.70 and mean of hand grip was 18.1±7.1N. Current treatment: glucocorticoids: 61.7%(n=29), conventional DMARDs (Disease Modifying Anti-Rheumatic Drugs): 80.9%(n=38) and biological DMARDs: 48.9%(n=23). There were found 43 erosions (0.9±1.2/patient) and 14 osteophytes (0.3±0.7/patient) in the 2ndMCP head. The joint gap mean was 80.6±34.9mm3, and erosion volume median was 0.26(0, 16.16) mm3. Volume of cortical bone erosions was negatively correlated with BMD in 2ndMCP head (r= -0.53, p< 0.001), VOI-4 (r= -0.48, p=0.017) and joint gap (r= -0.40, p=0.005); and it was positively correlated with number of erosions (r= 0.82, p< 0.001) and number of osteophytes (r= 0.32, p= 0.026).  Furthermore, after the sample was categorized by absence or presence of erosion in 2ndMCP head it was found a significant difference between number of osteophyte (0.10±0.41vs.0.50±0.88, p=0.028), BMD of MCP head (321.53±37.12 vs.281.38±67.69mg/cm3, p=0.043) (Figure 2) and joint gap (93.59±36.94 vs.68.20±28.31, p=0.025), respectively.  The multiple linear regression showed that BMD of 2ndMCP head was negatively associated with its volume of erosion (B= – 0.813, p=0.003, adjusted R2= 0.32), adjusted by number of erosions, number of osteophytes, joint gap, VOI-4 and volumetric trabecular BMD of radius.

Conclusion: Cortical bone erosions volume were associated with low BMD in the 2 nd MCP head, suggesting that this variable should also be included as an outcome parameter in the follow-up of RA patients.

Funding:Camille P. Figueiredo was supported by FAPESP (2018/01315-9). This work was supported by FAPESP 2016/00006-7.

References:

1-Tam LS. J Rheumatol 2016;43(10):1911-3.

2-Figueiredo CP, et al.  Semin Arthritis Rheum 2017;47(7):611-8.

Figure 1: HR-pQCT imaging of 2nd MCP head from a RA patient -coronal plane-. Demonstration of bone segmentation by MIAF, showing BMD of MCP head analyzed -orange line-, erosion segmentation placed on radial quadrant -green line- and VOIs -1 to 4- -blue lines around erosion-.

Figure 2: Axial plane of 2nd MCP head using HR-pQCT scan comparing two RA patients with erosion on radial quadrant. First patient: -A- erosion volume=6.75mm3 with 4 VOIs segmentation -blue lines- and -B- BMD segmentation -purple contouring=314.94mg/cm3-. Second patient: -C- an important erosion volume= 19.33mm3 with 4 VOIs segmentation -blue lines- and -D- BMD segmentation -purple contouring=284.63mg/cm3-.


Disclosure: C. Figueiredo, None; M. Perez, None; A. Ribeiro, None; V. Caparbo, None; R. Pereira, None.

To cite this abstract in AMA style:

Figueiredo C, Perez M, Ribeiro A, Caparbo V, Pereira R. Cortical Bone Erosion in the 2nd Metacarpal Bone Head: Association with Its Bone Mineral Density by HR-pQCT in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cortical-bone-erosion-in-the-2nd-metacarpal-bone-head-association-with-its-bone-mineral-density-by-hr-pqct-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cortical-bone-erosion-in-the-2nd-metacarpal-bone-head-association-with-its-bone-mineral-density-by-hr-pqct-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology